| 0 |
APPLICATION SITE MACULE |
1 |
0.0667 |
| 1 |
COLPOSCOPY ABNORMAL |
1 |
0.0455 |
| 2 |
RECTOCELE REPAIR |
1 |
0.0169 |
| 3 |
PHLEBITIS DEEP |
1 |
0.0135 |
| 4 |
ALLERGY TO ARTHROPOD STING |
3 |
0.0066 |
| 5 |
PAIN MANAGEMENT |
1 |
0.0059 |
| 6 |
HYDROMETRA |
1 |
0.0054 |
| 7 |
HERPES SIMPLEX TEST POSITIVE |
1 |
0.0050 |
| 8 |
APPLICATION SITE HYPOAESTHESIA |
1 |
0.0043 |
| 9 |
TUBULOINTERSTITIAL NEPHRITIS AND UVEITIS SYNDROME |
1 |
0.0040 |
| 10 |
KERATOMILEUSIS |
1 |
0.0039 |
| 11 |
VICTIM OF ABUSE |
1 |
0.0037 |
| 12 |
ASTHMA EXERCISE INDUCED |
1 |
0.0029 |
| 13 |
ENDOMETRIAL ABLATION |
1 |
0.0028 |
| 14 |
KERATOCONUS |
1 |
0.0027 |
| 15 |
POLYCYSTIC OVARIAN SYNDROME |
1 |
0.0026 |
| 16 |
VIRAL PHARYNGITIS |
1 |
0.0025 |
| 17 |
REFLUX LARYNGITIS |
1 |
0.0023 |
| 18 |
MECHANICAL URTICARIA |
1 |
0.0021 |
| 19 |
SLEEP ATTACKS |
1 |
0.0021 |
| 20 |
ECZEMA EYELIDS |
1 |
0.0018 |
| 21 |
URINARY TRACT INFECTION FUNGAL |
1 |
0.0017 |
| 22 |
ALLERGY TO METALS |
1 |
0.0016 |
| 23 |
BORDERLINE PERSONALITY DISORDER |
1 |
0.0014 |
| 24 |
PARASOMNIA |
1 |
0.0014 |
| 25 |
OPTIC NERVE DISORDER |
2 |
0.0012 |
| 26 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
1 |
0.0011 |
| 27 |
PHARYNGEAL HYPOAESTHESIA |
1 |
0.0011 |
| 28 |
SLEEP-RELATED EATING DISORDER |
1 |
0.0011 |
| 29 |
METABOLIC SURGERY |
1 |
0.0009 |
| 30 |
RENAL ATROPHY |
1 |
0.0008 |
| 31 |
BENIGN INTRACRANIAL HYPERTENSION |
1 |
0.0008 |
| 32 |
OVARIAN CYST RUPTURED |
1 |
0.0008 |
| 33 |
APPLICATION SITE PARAESTHESIA |
1 |
0.0008 |
| 34 |
RENAL ARTERY STENOSIS |
1 |
0.0007 |
| 35 |
APPLICATION SITE INFLAMMATION |
1 |
0.0007 |
| 36 |
SMEAR CERVIX ABNORMAL |
1 |
0.0007 |
| 37 |
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY |
1 |
0.0007 |
| 38 |
NECK INJURY |
2 |
0.0007 |
| 39 |
GENERALISED ANXIETY DISORDER |
1 |
0.0007 |
| 40 |
ACNE CYSTIC |
2 |
0.0007 |
| 41 |
PRODUCT DEPOSIT |
1 |
0.0006 |
| 42 |
INAPPROPRIATE AFFECT |
1 |
0.0006 |
| 43 |
OROPHARYNGEAL BLISTERING |
1 |
0.0006 |
| 44 |
EXPOSURE DURING BREAST FEEDING |
2 |
0.0006 |
| 45 |
APPLICATION SITE SWELLING |
3 |
0.0006 |
| 46 |
MITRAL VALVE PROLAPSE |
1 |
0.0006 |
| 47 |
APPLICATION SITE DRYNESS |
2 |
0.0006 |
| 48 |
VERTIGO POSITIONAL |
1 |
0.0006 |
| 49 |
APPLICATION SITE EXFOLIATION |
2 |
0.0005 |
| 50 |
EXPIRED PRODUCT ADMINISTERED |
16 |
0.0005 |
| 51 |
MELANOCYTIC NAEVUS |
2 |
0.0005 |
| 52 |
CORNEAL DISORDER |
1 |
0.0005 |
| 53 |
APPLICATION SITE PAIN |
10 |
0.0005 |
| 54 |
TONGUE BLISTERING |
1 |
0.0004 |
| 55 |
INFECTIOUS MONONUCLEOSIS |
1 |
0.0004 |
| 56 |
PAPILLOEDEMA |
2 |
0.0004 |
| 57 |
EYELID DISORDER |
1 |
0.0004 |
| 58 |
SKIN TIGHTNESS |
2 |
0.0004 |
| 59 |
DERMAL CYST |
1 |
0.0004 |
| 60 |
ANGLE CLOSURE GLAUCOMA |
1 |
0.0004 |
| 61 |
APPLICATION SITE ERYTHEMA |
10 |
0.0004 |
| 62 |
EXFOLIATIVE RASH |
1 |
0.0004 |
| 63 |
TEMPOROMANDIBULAR JOINT SYNDROME |
1 |
0.0004 |
| 64 |
ALCOHOL ABUSE |
1 |
0.0004 |
| 65 |
SKIN DISCOMFORT |
1 |
0.0004 |
| 66 |
THORACIC VERTEBRAL FRACTURE |
1 |
0.0003 |
| 67 |
REBOUND ACID HYPERSECRETION |
1 |
0.0003 |
| 68 |
THROMBOPHLEBITIS SUPERFICIAL |
1 |
0.0003 |
| 69 |
ACNE |
25 |
0.0003 |
| 70 |
PIGMENTATION DISORDER |
2 |
0.0003 |
| 71 |
PRE-EXISTING CONDITION IMPROVED |
2 |
0.0003 |
| 72 |
HANGOVER |
1 |
0.0003 |
| 73 |
SKIN DISCOLOURATION |
13 |
0.0003 |
| 74 |
FACIAL PARESIS |
1 |
0.0003 |
| 75 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
2 |
0.0003 |
| 76 |
MAJOR DEPRESSION |
2 |
0.0003 |
| 77 |
TENDON INJURY |
1 |
0.0003 |
| 78 |
SNORING |
1 |
0.0003 |
| 79 |
BOWEL MOVEMENT IRREGULARITY |
2 |
0.0003 |
| 80 |
PANIC DISORDER |
1 |
0.0003 |
| 81 |
EPIGASTRIC DISCOMFORT |
1 |
0.0003 |
| 82 |
PRODUCT ADMINISTRATION INTERRUPTED |
2 |
0.0003 |
| 83 |
VULVOVAGINAL MYCOTIC INFECTION |
1 |
0.0003 |
| 84 |
ENURESIS |
1 |
0.0002 |
| 85 |
APPLICATION SITE DISCOLOURATION |
1 |
0.0002 |
| 86 |
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE |
1 |
0.0002 |
| 87 |
ANAPHYLACTOID REACTION |
1 |
0.0002 |
| 88 |
EYE SWELLING |
9 |
0.0002 |
| 89 |
APPLICATION SITE IRRITATION |
3 |
0.0002 |
| 90 |
SLEEP TERROR |
1 |
0.0002 |
| 91 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
4 |
0.0002 |
| 92 |
POOR PERIPHERAL CIRCULATION |
1 |
0.0002 |
| 93 |
PRODUCT DISPENSING ISSUE |
1 |
0.0002 |
| 94 |
ABNORMAL SENSATION IN EYE |
1 |
0.0002 |
| 95 |
APPLICATION SITE PRURITUS |
5 |
0.0002 |
| 96 |
EAR DISORDER |
1 |
0.0002 |
| 97 |
EYE OPERATION |
1 |
0.0002 |
| 98 |
TIBIA FRACTURE |
1 |
0.0002 |
| 99 |
GUILLAIN-BARRE SYNDROME |
1 |
0.0002 |
| 100 |
EXPIRED DRUG ADMINISTERED |
1 |
0.0002 |
| 101 |
HYPERNATRAEMIA |
1 |
0.0002 |
| 102 |
OVARIAN CYST |
2 |
0.0002 |
| 103 |
DRUG TOLERANCE |
1 |
0.0002 |
| 104 |
PRODUCT COLOUR ISSUE |
1 |
0.0002 |
| 105 |
POLYARTHRITIS |
1 |
0.0002 |
| 106 |
CHEILITIS |
1 |
0.0002 |
| 107 |
BACK INJURY |
2 |
0.0002 |
| 108 |
HYDROCEPHALUS |
1 |
0.0002 |
| 109 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
1 |
0.0002 |
| 110 |
PERIORBITAL SWELLING |
1 |
0.0002 |
| 111 |
DERMATITIS CONTACT |
2 |
0.0002 |
| 112 |
SWELLING FACE |
11 |
0.0002 |
| 113 |
RESTLESS LEGS SYNDROME |
3 |
0.0002 |
| 114 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0002 |
| 115 |
FOREIGN BODY SENSATION IN EYES |
1 |
0.0002 |
| 116 |
BURNING SENSATION |
11 |
0.0002 |
| 117 |
ANGINA UNSTABLE |
1 |
0.0002 |
| 118 |
TENDON DISORDER |
1 |
0.0002 |
| 119 |
SOMNAMBULISM |
1 |
0.0002 |
| 120 |
POSTOPERATIVE WOUND INFECTION |
1 |
0.0001 |
| 121 |
ECCHYMOSIS |
1 |
0.0001 |
| 122 |
PERIPHERAL COLDNESS |
2 |
0.0001 |
| 123 |
APPLICATION SITE RASH |
2 |
0.0001 |
| 124 |
DROOLING |
1 |
0.0001 |
| 125 |
APPLICATION SITE REACTION |
1 |
0.0001 |
| 126 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 127 |
RASH PUSTULAR |
1 |
0.0001 |
| 128 |
UTERINE LEIOMYOMA |
1 |
0.0001 |
| 129 |
SENSITIVE SKIN |
1 |
0.0001 |
| 130 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 131 |
DRY SKIN |
18 |
0.0001 |
| 132 |
GENERAL SYMPTOM |
1 |
0.0001 |
| 133 |
COLITIS |
5 |
0.0001 |
| 134 |
PRODUCT AVAILABILITY ISSUE |
3 |
0.0001 |
| 135 |
SKIN IRRITATION |
6 |
0.0001 |
| 136 |
MATERNAL DRUGS AFFECTING FOETUS |
1 |
0.0001 |
| 137 |
FOOD ALLERGY |
1 |
0.0001 |
| 138 |
CONCUSSION |
1 |
0.0001 |
| 139 |
ERYTHEMA |
26 |
0.0001 |
| 140 |
FURUNCLE |
1 |
0.0001 |
| 141 |
BLOOD DISORDER |
1 |
0.0001 |
| 142 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 143 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 144 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 145 |
MUSCULOSKELETAL DISCOMFORT |
2 |
0.0001 |
| 146 |
HYSTERECTOMY |
1 |
0.0001 |
| 147 |
SKIN SWELLING |
1 |
0.0001 |
| 148 |
GALLBLADDER DISORDER |
2 |
0.0001 |
| 149 |
FACIAL PAIN |
1 |
0.0001 |
| 150 |
SKIN BURNING SENSATION |
8 |
0.0001 |
| 151 |
HIDRADENITIS |
1 |
0.0001 |
| 152 |
INTERVERTEBRAL DISC DEGENERATION |
1 |
0.0001 |
| 153 |
APPENDICITIS |
1 |
0.0001 |
| 154 |
ORAL HERPES |
2 |
0.0001 |
| 155 |
VITREOUS FLOATERS |
1 |
0.0001 |
| 156 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 157 |
DRY THROAT |
1 |
0.0001 |
| 158 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 159 |
BODY HEIGHT DECREASED |
1 |
0.0001 |
| 160 |
BIPOLAR DISORDER |
1 |
0.0001 |
| 161 |
INTERVERTEBRAL DISC PROTRUSION |
2 |
0.0001 |
| 162 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 163 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 164 |
SUICIDAL IDEATION |
8 |
0.0001 |
| 165 |
SEXUAL DYSFUNCTION |
1 |
0.0001 |
| 166 |
RASH ERYTHEMATOUS |
4 |
0.0001 |
| 167 |
SKIN EXFOLIATION |
7 |
0.0001 |
| 168 |
INJECTION SITE URTICARIA |
2 |
0.0001 |
| 169 |
PHARYNGITIS |
1 |
0.0001 |
| 170 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
| 171 |
INJECTION SITE DISCOLOURATION |
1 |
0.0001 |
| 172 |
MYDRIASIS |
1 |
0.0001 |
| 173 |
INCORRECT PRODUCT STORAGE |
1 |
0.0001 |
| 174 |
BEDRIDDEN |
1 |
0.0001 |
| 175 |
DERMATITIS ATOPIC |
4 |
0.0001 |
| 176 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 177 |
JOINT RANGE OF MOTION DECREASED |
1 |
0.0001 |
| 178 |
PRODUCT QUALITY ISSUE |
10 |
0.0001 |
| 179 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 180 |
BRONCHOSPASM |
1 |
0.0001 |
| 181 |
GASTROENTERITIS |
1 |
0.0001 |
| 182 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 183 |
LACRIMATION INCREASED |
2 |
0.0001 |
| 184 |
CONTRAINDICATED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 185 |
OSTEOPENIA |
1 |
0.0001 |
| 186 |
NEPHROLITHIASIS |
3 |
0.0001 |
| 187 |
PRURITUS |
25 |
0.0001 |
| 188 |
PHARYNGEAL OEDEMA |
1 |
0.0001 |
| 189 |
TENDONITIS |
1 |
0.0001 |
| 190 |
EXPOSURE DURING PREGNANCY |
4 |
0.0001 |
| 191 |
SWOLLEN TONGUE |
2 |
0.0001 |
| 192 |
MIGRAINE |
6 |
0.0001 |
| 193 |
PREMATURE DELIVERY |
1 |
0.0001 |
| 194 |
BACK DISORDER |
1 |
0.0001 |
| 195 |
MULTIPLE FRACTURES |
1 |
0.0001 |
| 196 |
VISUAL ACUITY REDUCED |
2 |
0.0001 |
| 197 |
FACE OEDEMA |
1 |
0.0001 |
| 198 |
SCAR |
1 |
0.0001 |
| 199 |
ECZEMA |
3 |
0.0001 |
| 200 |
LOCAL SWELLING |
1 |
0.0001 |
| 201 |
HYPOXIA |
2 |
0.0001 |
| 202 |
THERAPY INTERRUPTED |
4 |
0.0001 |
| 203 |
TREATMENT NONCOMPLIANCE |
3 |
0.0001 |
| 204 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 205 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 206 |
BRONCHITIS |
4 |
0.0001 |
| 207 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 208 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 209 |
THINKING ABNORMAL |
1 |
0.0001 |
| 210 |
SWELLING |
5 |
0.0001 |
| 211 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 212 |
GASTRIC ULCER |
1 |
0.0001 |
| 213 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 214 |
BLOOD PRESSURE INCREASED |
8 |
0.0001 |
| 215 |
WHITE BLOOD CELL COUNT INCREASED |
2 |
0.0001 |
| 216 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 217 |
SKIN FISSURES |
1 |
0.0001 |
| 218 |
KIDNEY INFECTION |
1 |
0.0001 |
| 219 |
MENORRHAGIA |
1 |
0.0001 |
| 220 |
RASH |
22 |
0.0001 |
| 221 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 222 |
IRRITABILITY |
3 |
0.0000 |
| 223 |
NO ADVERSE EVENT |
9 |
0.0000 |
| 224 |
EXTRA DOSE ADMINISTERED |
2 |
0.0000 |
| 225 |
HYPERSENSITIVITY |
9 |
0.0000 |
| 226 |
ROAD TRAFFIC ACCIDENT |
2 |
0.0000 |
| 227 |
DERMATITIS |
1 |
0.0000 |
| 228 |
RETCHING |
1 |
0.0000 |
| 229 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 230 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 231 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 232 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 233 |
THROAT IRRITATION |
2 |
0.0000 |
| 234 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 235 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 236 |
AGEUSIA |
1 |
0.0000 |
| 237 |
DRY EYE |
2 |
0.0000 |
| 238 |
DEPRESSION |
9 |
0.0000 |
| 239 |
HYPOPHAGIA |
1 |
0.0000 |
| 240 |
ACCIDENTAL EXPOSURE TO PRODUCT |
4 |
0.0000 |
| 241 |
INFLAMMATION |
2 |
0.0000 |
| 242 |
ABDOMINAL DISTENSION |
4 |
0.0000 |
| 243 |
SEDATION |
1 |
0.0000 |
| 244 |
ANHEDONIA |
1 |
0.0000 |
| 245 |
GASTRITIS |
1 |
0.0000 |
| 246 |
DISTURBANCE IN ATTENTION |
2 |
0.0000 |
| 247 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 248 |
RASH PRURITIC |
2 |
0.0000 |
| 249 |
PALLOR |
1 |
0.0000 |
| 250 |
MOOD ALTERED |
1 |
0.0000 |
| 251 |
SKIN LESION |
1 |
0.0000 |
| 252 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0000 |
| 253 |
HAEMATOCHEZIA |
2 |
0.0000 |
| 254 |
DIVERTICULITIS |
1 |
0.0000 |
| 255 |
URTICARIA |
6 |
0.0000 |
| 256 |
BLISTER |
2 |
0.0000 |
| 257 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 258 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 259 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 260 |
PRODUCT SUBSTITUTION ISSUE |
2 |
0.0000 |
| 261 |
DYSSTASIA |
1 |
0.0000 |
| 262 |
INTENTIONAL PRODUCT USE ISSUE |
3 |
0.0000 |
| 263 |
SURGERY |
2 |
0.0000 |
| 264 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 265 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 266 |
RENAL INJURY |
1 |
0.0000 |
| 267 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 268 |
CONDITION AGGRAVATED |
10 |
0.0000 |
| 269 |
DISCOMFORT |
2 |
0.0000 |
| 270 |
DRUG ADMINISTRATION ERROR |
1 |
0.0000 |
| 271 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 272 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 273 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 274 |
PARAESTHESIA |
5 |
0.0000 |
| 275 |
HEAD INJURY |
1 |
0.0000 |
| 276 |
CYSTITIS |
1 |
0.0000 |
| 277 |
MOOD SWINGS |
1 |
0.0000 |
| 278 |
CHOLELITHIASIS |
1 |
0.0000 |
| 279 |
EYE DISORDER |
1 |
0.0000 |
| 280 |
LIP SWELLING |
1 |
0.0000 |
| 281 |
DEHYDRATION |
4 |
0.0000 |
| 282 |
URINARY RETENTION |
1 |
0.0000 |
| 283 |
ANGER |
1 |
0.0000 |
| 284 |
INJECTION SITE REACTION |
2 |
0.0000 |
| 285 |
RASH MACULAR |
1 |
0.0000 |
| 286 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 287 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
2 |
0.0000 |
| 288 |
PRODUCT ADHESION ISSUE |
1 |
0.0000 |
| 289 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1 |
0.0000 |
| 290 |
PANIC ATTACK |
1 |
0.0000 |
| 291 |
RESTLESSNESS |
1 |
0.0000 |
| 292 |
PRODUCT USE ISSUE |
5 |
0.0000 |
| 293 |
DRUG INEFFECTIVE |
35 |
0.0000 |
| 294 |
PERIPHERAL SWELLING |
4 |
0.0000 |
| 295 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 296 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 297 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 298 |
OSTEOPOROSIS |
1 |
0.0000 |
| 299 |
DIZZINESS |
12 |
0.0000 |
| 300 |
WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 301 |
MENTAL DISORDER |
1 |
0.0000 |
| 302 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
| 303 |
DRUG WITHDRAWAL SYNDROME |
2 |
0.0000 |
| 304 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 305 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 306 |
VISION BLURRED |
3 |
0.0000 |
| 307 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 308 |
ABDOMINAL PAIN |
5 |
0.0000 |
| 309 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 310 |
ANXIETY |
6 |
0.0000 |
| 311 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 312 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 313 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 314 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 315 |
ALOPECIA |
4 |
0.0000 |
| 316 |
DYSPEPSIA |
2 |
0.0000 |
| 317 |
SOMNOLENCE |
4 |
0.0000 |
| 318 |
FLUID RETENTION |
1 |
0.0000 |
| 319 |
SINUSITIS |
2 |
0.0000 |
| 320 |
ILLNESS |
2 |
0.0000 |
| 321 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 322 |
DEPRESSED MOOD |
1 |
0.0000 |
| 323 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 324 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 325 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 326 |
WEIGHT DECREASED |
5 |
0.0000 |
| 327 |
PAIN |
11 |
0.0000 |
| 328 |
NECK PAIN |
1 |
0.0000 |
| 329 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 330 |
HERPES ZOSTER |
1 |
0.0000 |
| 331 |
SEIZURE |
2 |
0.0000 |
| 332 |
PALPITATIONS |
2 |
0.0000 |
| 333 |
DIARRHOEA |
11 |
0.0000 |
| 334 |
NASAL CONGESTION |
1 |
0.0000 |
| 335 |
WHEEZING |
1 |
0.0000 |
| 336 |
FEELING ABNORMAL |
4 |
0.0000 |
| 337 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 338 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 339 |
STOMATITIS |
1 |
0.0000 |
| 340 |
VERTIGO |
1 |
0.0000 |
| 341 |
MUSCLE SPASMS |
3 |
0.0000 |
| 342 |
FEELING HOT |
1 |
0.0000 |
| 343 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 344 |
PRODUCT USE IN UNAPPROVED INDICATION |
4 |
0.0000 |
| 345 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 346 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 347 |
DEVICE EXPULSION |
1 |
0.0000 |
| 348 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 349 |
AMNESIA |
1 |
0.0000 |
| 350 |
PSORIASIS |
2 |
0.0000 |
| 351 |
NAUSEA |
12 |
0.0000 |
| 352 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 353 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 354 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 355 |
SLEEP DISORDER |
1 |
0.0000 |
| 356 |
MOBILITY DECREASED |
1 |
0.0000 |
| 357 |
PAIN IN EXTREMITY |
4 |
0.0000 |
| 358 |
HOT FLUSH |
1 |
0.0000 |
| 359 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 360 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 361 |
DIABETES MELLITUS |
1 |
0.0000 |
| 362 |
INJECTION SITE PAIN |
4 |
0.0000 |
| 363 |
BACK PAIN |
3 |
0.0000 |
| 364 |
DRUG INTERACTION |
2 |
0.0000 |
| 365 |
OFF LABEL USE |
11 |
0.0000 |
| 366 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 367 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 368 |
DRY MOUTH |
1 |
0.0000 |
| 369 |
DRUG DOSE OMISSION |
2 |
0.0000 |
| 370 |
COMPLETED SUICIDE |
1 |
0.0000 |
| 371 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 372 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 373 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 374 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 375 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 376 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 377 |
CONTUSION |
1 |
0.0000 |
| 378 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 379 |
HYPOTENSION |
2 |
0.0000 |
| 380 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 381 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 382 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 383 |
CONSTIPATION |
2 |
0.0000 |
| 384 |
MALAISE |
4 |
0.0000 |
| 385 |
INFLUENZA |
1 |
0.0000 |
| 386 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 387 |
WEIGHT INCREASED |
2 |
0.0000 |
| 388 |
ASTHMA |
1 |
0.0000 |
| 389 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 390 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 391 |
DECREASED APPETITE |
2 |
0.0000 |
| 392 |
CHILLS |
1 |
0.0000 |
| 393 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 394 |
HEADACHE |
5 |
0.0000 |
| 395 |
HYPERHIDROSIS |
1 |
0.0000 |
| 396 |
RENAL FAILURE |
1 |
0.0000 |
| 397 |
ARTHRALGIA |
3 |
0.0000 |
| 398 |
COUGH |
2 |
0.0000 |
| 399 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 400 |
HYPOAESTHESIA |
1 |
0.0000 |
| 401 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 402 |
HOSPITALISATION |
1 |
0.0000 |
| 403 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 404 |
PNEUMONIA |
2 |
0.0000 |
| 405 |
FALL |
2 |
0.0000 |
| 406 |
MYALGIA |
1 |
0.0000 |
| 407 |
PYREXIA |
2 |
0.0000 |
| 408 |
COVID-19 |
1 |
0.0000 |
| 409 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 410 |
CHEST PAIN |
1 |
0.0000 |
| 411 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 412 |
FATIGUE |
4 |
0.0000 |
| 413 |
HYPERTENSION |
1 |
0.0000 |
| 414 |
VOMITING |
2 |
0.0000 |
| 415 |
INSOMNIA |
1 |
0.0000 |
| 416 |
DEATH |
2 |
0.0000 |
| 417 |
DYSPNOEA |
1 |
0.0000 |